PD-L1 expression, tumor-infiltrating lymphocytes, mismatch repair deficiency, EGFR alteration and HPV infection in sinonasal squamous cell carcinoma-Reference-Cited by-同舟云学术

PD-L1 expression, tumor-infiltrating lymphocytes, mismatch repair deficiency, EGFR alteration and HPV infection in sinonasal squamous cell carcinoma

Published:2021-07-03 Issue:11 Volume:34 Page:1966-1978
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Hongo Takahiro,Yamamoto Hidetaka^ORCID,Jiromaru Rina,Yasumatsu Ryuji,Kuga Ryosuke,Nozaki Yui,Hashimoto Kazuki,Matsuo Mioko,Wakasaki Takahiro,Tamae Akihiro,Taguchi Kenichi,Toh Satoshi,Masuda Muneyuki,Nakagawa Takashi,Oda Yoshinao

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

https://www.nature.com/articles/s41379-021-00868-w.pdf

Reference54 articles.

1. Llorente JL, Lopez F, Suarez C, Hermsen MA. Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances. Nat Rev Clin Oncol. 2014;11:460–72.

2. Ansa B, Goodman M, Ward K, Kono SA, OwonikokoTK, Higgins K, et al. Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009. Cancer. 2013;119:2602–10.

3. Hongo T, Yamamoto H, Jiromaru R, Nozaki Y, Yasumatsu R, Hashimoto K, et al. Clinicopathologic significance of EGFR mutation and HPV infection in sinonasal squamous cell carcinoma. Am J Surg Pathol. 2021;45:108–18.

4. Rooper LM, Bishop JA, Westra WH. Transcriptionally active high-risk human papillomavirus is not a common etiologic agent in the malignant transformation of inverted Schneiderian papillomas. Head Neck Pathol. 2017;11:346–53.

5. Sasaki E, Nishikawa D, Hanai N, Hasegawa Y, Yatabe Y. Sinonasal squamous cell carcinoma and EGFR mutations: a molecular footprint of a benign lesion. Histopathology. 2018;73:953–62.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complete remission in a patient with sinonasal squamous cell carcinoma receiving neoadjuvant tislelizumab plus chemotherapy: a case report;Frontiers in Immunology;2024-07-15

2. Tumor immune microenvironment in odontogenic carcinomas: Evaluation of the therapeutic potential of immune checkpoint blockade;Journal of Oral Pathology & Medicine;2024-03

3. Recent advances in molecular pathological findings in sinonasal carcinomas;Okayama Igakkai Zasshi (Journal of Okayama Medical Association);2023-12-01

4. Low-dose nivolumab and cabozantinib in recurrent intestinal-type papillary adenocarcinoma of the sinonasal region;BMJ Case Reports;2023-11

5. γδT cells in patients with tumors of the nasal cavity and paranasal sinuses;Medical Immunology (Russia);2023-10-17